Aurigene reports promising phase-1 data for its CAR-T therapy against myelomaAurigene Oncology has announced promising phase-1 results for its novel CAR-T cell therapy, Ribrecabtagene autoleucel, in patients with mul...
08 Oct, 2024, 04.56 PM IST
Stocks in news: ZEE, M&M Financial, Dr Reddy's, Wipro, BioconDomestic markets rally on exit polls predicting Modi government's massive mandate. ZEE, M&M Financial, Dr Reddy's, Wipro, Biocon in focus. ...
04 Jun, 2024, 07.34 AM IST
Aurigene Pharmaceutical Services to set up USD 40 mn facility in HyderabadAurigene Pharmaceutical Services Ltd will establish its state-of-the-art biomanufacturing facility at an investment of USD 40 million here,...
04 Jul, 2023, 04.10 PM IST
Dr Reddy's, arm tie up with Swiss NGO to treat neglected diseasesAs per the memorandum of understanding (MoU) agreement, DNDi will offer its pipeline of new chemical entities, pre-clinical studies, networ...
31 Aug, 2022, 12.29 AM IST
Aurigene inks drug discovery, development pact with US-based EQRxUnder the terms of the collaboration agreement, Aurigene and EQRx will collaborate on drug discovery, pre-clinical and clinical development...
04 Jul, 2022, 03.21 PM IST
Dr Reddy's arm inks pact with US-based Olema PharmaceuticalsAurigene will also be eligible for up to USD 60 million in potential clinical development and regulatory milestones and up to USD 370 milli...
09 Jun, 2022, 10.27 PM IST
Like IT sector in the past, everything's coming together for pharma now: GV PrasadIndia is well positioned to be a dominant force in the global generics industry and that is showing.
22 Sep, 2020, 03.27 PM IST
C-CAMP launches fourth edition of bio-entrepreneurship competitionNBEC, India’s largest and most prestigious national competition for bio entrepreneurs is held by C-CAMP every year to attract, identify and...
07 Sep, 2020, 10.29 PM IST
Medical breakthrough! Aurigene closer to developing cancer treatment capsuleThe Bengaluru-based company is an independent subsidiary of Dr Reddy’s Laboratories and its United States-based partner Curis Inc.
01 Jul, 2016, 06.50 AM IST
DRL's Aurigene ties up with US firm CurisCuris has agreed to make payments of up to $52.5 million per programme including $42.5 million for approval and commercial milestones,
22 Jan, 2015, 08.49 PM IST
New drug approves immunotherapy for Cancer treatmentMerck’s competitors have lined up their own immunotherapy drugs. They include Bristol Myers Squibb (BMS), Roche & Novartis & several smalle...
12 Sep, 2014, 04.00 AM IST
India's drug discovery and development: Small research firms aim to change face of cancer therapyIndia is not known for developing drugs, let along cancer drugs, but a few small and niche firms are trying exactly that, reports ET.
08 May, 2014, 04.55 AM IST
- Global biotech firms seek partnerships in India for bigger gains
The global biotechnology industry is moving towards strategic partnerships in a bid to create faster and cost-efficient means of drug disco...
07 Jun, 2010, 01.07 AM IST
- Stocks to watch: ICICI Bank, Bajaj Finserv, TVS Motor, Apollo Hospitals,Ranbaxy, Dr Reddys, Reliance Capital
Oil prices remained steady in Asian trade on signs of rising energy demand in the United States. In morning trade, New York's main futures ...
22 May, 2009, 09.24 AM IST
- Dr Reddy's announces reorganisation of its drug discovery biz
Drug firm Dr Reddy's Lab (DRL) on Thursday said it will hive off its drug discovery business to a wholly-owned subsidiary, Aurigene, and wi...
21 May, 2009, 06.18 PM IST
- India more mature for drug discovery than China: Report
Rising research and development initiatives in the pharma sector has made India a more mature place for drug discovery activities than Chin...
15 Jun, 2008, 11.22 AM IST
- Aurigene tech enters collaboration with Forest Labs
The company has also entered into a discovery collaboration with biotechnology company Merck Serono International
02 Feb, 2007, 05.10 PM IST